Credit Suisse July 14, 2020
Jailendra Singh, Jermaine Brown, Adam Heussner

An Underpenetrated, Attractive TAM Driven by Growing Chronic Care Population. We initiate coverage of Livongo, a digital health platform providing its members with solutions for their chronic health conditions, with an Outperform rating and $132 TP. LVGO operates in a highly underpenetrated and growing chronic care market. With a little over $350 mln in annual rev (CS 2020 est), LVGO is barely scratching the surface in a market which the company sizes at $46.7 bln (combined TAM for U.S. opportunities in diabetes & hypertension). We believe this estimate is conservative for four reasons: 1) LVGO uses chronic disease prevalence and population estimates using 2015 data, which have moved exponentially higher today; 2) TAM does not incorporate its other solutions, Prediabetes...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Investments, Market Research, Technology, Trends
How Remote Patient Monitoring and AI Personalize Care
Digital Platforms Streamline Medication Access and Delivery
Too much data? Wearables for senior care have value but providers must know how to parse their output, experts say
Novel tech to answer nature’s call: Smartphone app provides real-time bladder data for seniors who need assistance
25 best healthcare software companies, per Healthcare Technology Report

Share This Article